November 25, 2018
In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
March 27, 2017
Since losing the fight for healthcare reform, Trump's administration has lost some momentum from companies and the market. It is...
January 30, 2017
Donald Trump's immigration ban has sparked outrage around the world, and biotech executives are speaking out.
December 26, 2016
2016 saw countless pharmaceutical companies taken to task for price gouging. Close to the end of the year, a related...
December 20, 2016
Allergan, a leading global biopharmaceutical company, and Acelity today announced that they have entered into a definitive agreement under which...
October 4, 2016
Six acquisitions indicate Allergan’s refined strategic focus, as well as CEO Brent Saunders’ continued commitment to a “growth pharma” business...
September 20, 2016
Allergan (NYSE:AGN) and Tobira Therapeutics, Inc. (NASDAQ: TBRA) announced that they have entered into a definitive agreement.